These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 32343971)
1. Molecular mechanisms of action of naringenin in chronic airway diseases. Chin LH; Hon CM; Chellappan DK; Chellian J; Madheswaran T; Zeeshan F; Awasthi R; Aljabali AA; Tambuwala MM; Dureja H; Negi P; Kapoor DN; Goyal R; Paudel KR; Satija S; Gupta G; Hsu A; Wark P; Mehta M; Wadhwa R; Hansbro PM; Dua K Eur J Pharmacol; 2020 Jul; 879():173139. PubMed ID: 32343971 [TBL] [Abstract][Full Text] [Related]
2. Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective. Zobeiri M; Belwal T; Parvizi F; Naseri R; Farzaei MH; Nabavi SF; Sureda A; Nabavi SM Curr Pharm Biotechnol; 2018; 19(3):196-205. PubMed ID: 29766801 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Joshi R; Kulkarni YA; Wairkar S Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464 [TBL] [Abstract][Full Text] [Related]
4. Characterization, in Vitro and in Vivo Evaluation of Naringenin-Hydroxypropyl-ß-Cyclodextrin Inclusion for Pulmonary Delivery. Guan M; Shi R; Zheng Y; Zeng X; Fan W; Wang Y; Su W Molecules; 2020 Jan; 25(3):. PubMed ID: 32012911 [TBL] [Abstract][Full Text] [Related]
6. Antinociceptive and anti-inflammatory effect of Naringenin in different nociceptive and inflammatory mice models. Xue N; Wu X; Wu L; Li L; Wang F Life Sci; 2019 Jan; 217():148-154. PubMed ID: 30414428 [TBL] [Abstract][Full Text] [Related]
7. Naringenin as a potential immunomodulator in therapeutics. Zeng W; Jin L; Zhang F; Zhang C; Liang W Pharmacol Res; 2018 Sep; 135():122-126. PubMed ID: 30081177 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology. Chen Z; Chen P; Wu H; Shi R; Su W; Wang Y; Li P Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302350 [TBL] [Abstract][Full Text] [Related]
9. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Shi Y; Dai J; Liu H; Li RR; Sun PL; Du Q; Pang LL; Chen Z; Yin KS Can J Physiol Pharmacol; 2009 Sep; 87(9):729-35. PubMed ID: 19794524 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect evaluation of naringenin and its incorporation into a chitosan-based film for transdermal delivery. Quintão WSC; Silva-Carvalho AE; Hilgert LA; Gratieri T; Cunha-Filho M; Saldanha-Araújo F; Gelfuso GM Int J Pharm; 2022 Nov; 627():122231. PubMed ID: 36167188 [TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and anti-arthritic properties of naringenin via attenuation of NF-κB and activation of the heme oxygenase ﴾HO﴿-1/related factor 2 pathway. Fan R; Pan T; Zhu AL; Zhang MH Pharmacol Rep; 2017 Oct; 69(5):1021-1029. PubMed ID: 28943290 [TBL] [Abstract][Full Text] [Related]
12. The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Salehi B; Fokou PVT; Sharifi-Rad M; Zucca P; Pezzani R; Martins N; Sharifi-Rad J Pharmaceuticals (Basel); 2019 Jan; 12(1):. PubMed ID: 30634637 [TBL] [Abstract][Full Text] [Related]
13. Naringenin Nano-Delivery Systems and Their Therapeutic Applications. Bhia M; Motallebi M; Abadi B; Zarepour A; Pereira-Silva M; Saremnejad F; Santos AC; Zarrabi A; Melero A; Jafari SM; Shakibaei M Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672366 [TBL] [Abstract][Full Text] [Related]
14. PVP- coated naringenin nanoparticles for biomedical applications - In vivo toxicological evaluations. Kumar RP; Abraham A Chem Biol Interact; 2016 Sep; 257():110-8. PubMed ID: 27417253 [TBL] [Abstract][Full Text] [Related]
15. Aerosolization Performance, Antitussive Effect and Local Toxicity of Naringenin-Hydroxypropyl-β-Cyclodextrin Inhalation Solution for Pulmonary Delivery. Guan M; Zeng X; Shi R; Zheng Y; Fan W; Su W AAPS PharmSciTech; 2021 Jan; 22(1):20. PubMed ID: 33389225 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro. Wadhwa R; Paudel KR; Chin LH; Hon CM; Madheswaran T; Gupta G; Panneerselvam J; Lakshmi T; Singh SK; Gulati M; Dureja H; Hsu A; Mehta M; Anand K; Devkota HP; Chellian J; Chellappan DK; Hansbro PM; Dua K J Food Biochem; 2021 Jan; 45(1):e13572. PubMed ID: 33249629 [TBL] [Abstract][Full Text] [Related]
17. Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential. Vij N Expert Opin Drug Deliv; 2011 Sep; 8(9):1105-9. PubMed ID: 21711085 [TBL] [Abstract][Full Text] [Related]
18. Naringenin: A flavanone with anti-inflammatory and anti-infective properties. Cai J; Wen H; Zhou H; Zhang D; Lan D; Liu S; Li C; Dai X; Song T; Wang X; He Y; He Z; Tan J; Zhang J Biomed Pharmacother; 2023 Aug; 164():114990. PubMed ID: 37315435 [TBL] [Abstract][Full Text] [Related]
19. Biological activities of naringenin: A narrative review based on in vitro and in vivo studies. Uçar K; Göktaş Z Nutr Res; 2023 Nov; 119():43-55. PubMed ID: 37738874 [TBL] [Abstract][Full Text] [Related]
20. A Review on Pharmacological and Analytical Aspects of Naringenin. Patel K; Singh GK; Patel DK Chin J Integr Med; 2018 Jul; 24(7):551-560. PubMed ID: 25501296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]